We hope to see everyone tonight from 4pm to 7pm at Pennovation Works for the PCI Ventures Showcase! The agenda is as follows: 4-5pm - Networking and Poster?Showcase 5-6pm - Opening remarks by Pennovation Works Managing Director, Denita L. Henderson, and PCIV Portfolio Manager, Bhavana Mohanraj then founders from Cogwear, Sahay AI, and Vasowatch will present? 6-7pm - Networking Register here: https://lnkd.in/eVpQU47U
关于我们
PCI Venture's mission is to maximize the potential of Penn's pioneering research to the benefit of the university, the investigative team, and society in general through the creation and stimulus of entrepreneurial endeavors. We provide a suite of products and services to incubate the development of early-stage technology-based businesses as they make their way toward commercial success. PCI Ventures actively seeks entrepreneurs to lead out companies and investors to provide funding for our portfolio of new ventures in development.
- 网站
-
https://www.pci.upenn.edu/pciventures/
PCI Ventures的外部链接
- 所属行业
- 高等教育
- 规模
- 2-10 人
- 总部
- Philadelphia,Pennsylvania
- 创立
- 2008
- 领域
- Addressable Market Analysis、Board-level Support、Commercialization Grant Support、Company Registration、Marketing Material Development、Educational Programs、Entrepreneurial Coaching、Executive-level Recruitment、Fundraising、IP Strategy Development和Strategic Partner Outreach
动态
-
Eric was a wonderful person and an invaluable member of the PCI Ventures community. We are deeply grateful to have had the privilege of knowing him.
The Penn Center for Innovation is deeply saddened by the passing of Eric Corkhill, who served as Chairman and CEO of Neuralert Technologies, a Penn spin-out company. Eric joined Neuralert in June 2020, working closely with co-founders Steven Messe (Professor of Neurology, Penn Medicine), James Weimer (Assistant Professor of Computer Science, Vanderbilt University), and CTO Det Ansinn, to achieve their objective of transforming the care of patients with stroke. ? Eric was an inspiring leader, and an exceptionally kind and generous person, who profoundly shaped Neuralert’s journey. Under Eric’s leadership, Neuralert made significant strides in their plans to develop the first lightweight, non-invasive device capable of providing continuous stroke monitoring and automatic alerts for timely treatments and improved outcomes.?Driven by his commitment to save lives and prevent disability after stroke, Eric led the company to milestone achievements including an?FDA?Breakthrough Device designation?in 2021?and Time Magazine’s recognition of Neuralert’s device as one of the?best inventions of 2022.?PCI Ventures celebrated Eric as?CEO of the Year in 2023?for his unwavering dedication and remarkable accomplishments. ? Eric’s contributions to Neuralert will endure as part of his legacy. Under the leadership of CEO, Det Ansinn, the Neuralert team is committed to fulfilling his vision for the company. ? The Penn Center for Innovation extends its deepest condolences to Eric’s family, friends, and colleagues. Eric will be greatly missed. ? For more information on Eric’s life and accomplishments, please refer to his?obituary: https://lnkd.in/eaQ4NdHp
-
Exciting news. PCI Ventures will be holding weekly office hours on Wednesdays in November and December. Each week, a member of the PCI Ventures team will be available to answer business questions on topics ranging from company formation and legal agreements to benefits and insurance. Anyone is welcome to take advantage of the office hours. The dates and times for these virtual sessions are as follows: ?? Melisa Lopez Anton, Nov 6 or Dec 11 (9am to 12pm EST) ?? Yi-Yen Chen, Nov 13 or Dec 4 (9am to 12pm EST) ?? Bhavana Mohanraj,?Nov 27 (10am to 1pm EST)?or?Dec 18 (9am to 12pm) Register here: https://lnkd.in/eghyVBxE
-
I hope everyone can make it to our annual showcase. It's a great opportunity to visit with many of the companies, but also reconnect with the community!
Exciting news! In celebration of its 14 years of service to the Penn community, PCI Ventures is bringing together a diverse group of entrepreneurs, faculty members, investors, and industry leaders for an evening of education and networking on November 20th for the PCIV Showcase. The Showcase will feature companies from PCI Ventures’ portfolio alongside Pennovation Works member companies. Learn more and register here: https://lnkd.in/gWrYwbEz
PCIV Showcase at Pennovation Works
pennovation.upenn.edu
-
Exciting news! In celebration of its 14 years of service to the Penn community, PCI Ventures is bringing together a diverse group of entrepreneurs, faculty members, investors, and industry leaders for an evening of education and networking on November 20th for the PCIV Showcase. The Showcase will feature companies from PCI Ventures’ portfolio alongside Pennovation Works member companies. Learn more and register here: https://lnkd.in/gWrYwbEz
PCIV Showcase at Pennovation Works
pennovation.upenn.edu
-
PCI Ventures is excited to announce that we're hosting another session of our Entrepreneurial Empowerment Series on Thursday, Oct 17th from 5-7pm at the Pennovation Center (Pennovation Works). The session is called "Small Steps for Big Returns: Best Practices when Working with Life Sciences Vendors and Service Providers" and it is designed exclusively for entrepreneurs and founders building new ventures. Experts Andrew Hamilton, Esq. and Jacqueline Berman, Esq., Partners at Morgan, Lewis & Bockius LLP, will speak on how to effectively work together with vendors and service providers to get the most out of your relationships. Learn more and register here: https://lu.ma/x5326j8e
-
PCI Ventures转发了
PCI, PCI Ventures and Yale Ventures are excited for Innovators Ignite: A Penn & Yale Showcase, where aspiring and diverse academic entrepreneurs from both universities will present promising technologies to a panel of industry experts. The event will take place virtually on September 17th and feature a diverse array of pioneering projects, from affordable robotic exercise systems for stroke rehabilitation to novel treatments for endometriosis and retinal degeneration. Venture capitalists, industry players, innovation enthusiasts, network builders and supporters of diversity from both university communities are welcome to attend. Penn's presenters will include: ?? Michelle Johnson, PhD, Associate Professor of Physical Medicine and Rehabilitation at the University of Pennsylvania, presenting Rehab CARES, a Rehab Community-Based Affordable Robotic Exercise Systems ?? Avery Posey, Jr., PhD,?Assistant Professor in the Department of Systems Pharmacology and Translational Therapeutics at Penn Medicine, presenting Immunocytokines to Enhance CAR T-cell Efficacy ?? Eileen Wang, MD, Professor of Clinical Obstetrics and Gynecology at Penn Medicine, presenting IUDINE, a postplacental IUD retention system ?? Akhila Mallavarapu, PhD, Postdoctoral Researcher at the Kagan Research Group, Department of Electrical and Systems Engineering (ESE) & Internet of Things for Precision Agriculture (IoT4Ag) Engineering Research Center at Penn Engineering, presenting on Biodegradable optical sensors for precision agriculture ?? Raghavi Sudharsan, PhD, Research Assistant Professor of Experimental Ophthalmology at Penn Medicine, presenting on Targeting PRLΔE1: A Novel Gene-Agnostic Strategy for Retinal Degeneration Therapy Read more about all of the teams presenting and access registration here: https://lnkd.in/eFNGRRp3
-
PCIV, Penn Center for Innovation, The Mack Institute and Wharton are co-hosting the Entrepreneurial Empowerment Series. This is a dynamic seminar series designed exclusively for entrepreneurs and founders building new ventures. The first session will take place on September 19th at the Pennovation Center. David Hsu, the Richard A. Sapp Professor of Management at Wharton, will present strategies for entrepreneurial commercialization of academic science. Expect to engage in lively discussion and walk away with actionable insights. Learn more and register here: https://lnkd.in/e2wRdYxm
-
PCI Ventures portfolio company EpiVario, Inc., a biotech company focusing on memory-related psychiatric disorders, received a $295,000 grant from the National Institute on Drug Abuse (NIDA) to research small molecule inhibitors for reducing cocaine craving and preventing relapse in Cocaine Use Disorder (CUD) patients. CUD, affecting millions in the U.S. alone, lacks FDA-approved pharmacological treatments, making EpiVario's epigenetic approach using ACSS2 inhibitors a promising new avenue. The grant will fund animal model studies, potentially leading to an Investigative New Drug (IND) application with the FDA and addressing the critical need for reliable CUD pharmacotherapy. Read more here:?https://lnkd.in/g7Mn7yHN
EpiVario Awarded NIH Grant to Advance Research in Treatments for Cocaine Use Disorder
ktla.com
-
PCI Ventures portfolio company Exyn Technologies, which offers advanced autonomy and mapping solutions, has partnered with Canadian unmanned technology provider Measur to expand its presence in Canada. Measur, which has grown significantly since its founding, will integrate Exyn's cutting-edge technologies like the Nexys 3D SLAM LiDAR payload to enhance safety, efficiency and cost savings for customers. This collaboration aims to provide robust and innovative geospatial solutions, leveraging Measur's expertise and Exyn's autonomous technologies to deliver even more advanced solutions to buyers. Learn more here: https://lnkd.in/gBEweBjy
Exyn Technologies Welcomes New Partner Measur Expanding Canadian Footprint
finance.yahoo.com